Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GuideAI HealthFRA:ZN0 +4.54%16 3-Year ROIIC % is 0.00 as of Jun. 2025. GuruFocus rates FRA:ZN0 with a GF Score™ of 16/100. Among 617 Healthcare Providers & Services companies, GuideAI Health ranks worse than 162074.39% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
GuideAI Health does not have enough data to calculate 3-Year ROIIC %.
GuideAI Health (FRA:ZN0) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
GuideAI Health 3-Year ROIIC % Related Terms
GuideAI Health 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for GuideAI Health's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GuideAI Health 3-Year ROIIC % Chart
GuideAI Health Annual Data
Trend
Jun23
Jun24
Jun25
3-Year ROIIC %
0.00
0.00
0.00
GuideAI Health Quarterly Data
Jun23
Jun24
Mar25
Jun25
Mar26
3-Year ROIIC %
0.00
0.00
0.00
0.00
0.00
FRA:ZN0 vs VEEV, BTSG, TEM: 3-Year ROIIC % Comparison
For the Health Information Services subindustry, GuideAI Health's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GuideAI Health 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GuideAI Health's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where GuideAI Health's 3-Year ROIIC % falls into.
GuideAI Health's 3-Year ROIIC % for the quarter that ended in Jun. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -0.846 (Jun. 2025) - (Jun. 2022) )
/
( 0.294 (Jun. 2025) - (Jun. 2022) )
=
/
=
N/A%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
GuideAI Health (FRA:ZN0) has a 3-Year ROIIC % of 0.00 as of Jun. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on GuideAI Health and its competitors. According to the industry distribution chart, GuideAI Health ranks #999999 out of 617 companies in the Healthcare Providers & Services industry.
Is GuideAI Health's 3-Year ROIIC % too high?
GuideAI Health's current 3-Year ROIIC % is 0.00. Based on the distribution chart, GuideAI Health ranks #999999 out of 617 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, GuideAI Health has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does GuideAI Health's 3-Year ROIIC % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, GuideAI Health ranks #999999 out of 617 companies for 3-Year ROIIC %. This places GuideAI Health in the lower half of its industry. The industry median 3-Year ROIIC % is 3.66. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.66, based on 617 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on GuideAI Health and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GuideAI Health's current 3-Year ROIIC % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GuideAI Health stock overvalued right now?
GuideAI Health (FRA:ZN0) has a current 3-Year ROIIC % of 0.00. The current 3-Year ROIIC % is 0.00. GuideAI Health's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For GuideAI Health (FRA:ZN0), the current 3-Year ROIIC % is 0.00 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GuideAI Health Corp is a healthcare technology company using artificial intelligence to enable the early detection of vascular disease and support more precise treatment decisions. Its platform analyzes routine CT scans to identify peripheral vascular disease and other vascular conditions that are frequently missed or under-reported, generating structured, actionable reports for radiologists and treating clinicians. By surfacing disease earlier and matching findings to appropriate treatment pathways, it aims to improve patient outcomes while helping hospitals and radiology groups deliver more comprehensive vascular care. Its Platform Capabilities are AI-powered vascular imaging, Early detection of disease, subtle patterns and risk signals, Structured, consistent AI-generated, and Others.
16GF Score
Get the complete analysis for FRA:ZN0
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ZN0 has been successfully added to your 
